< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  • Cleveland Clinic. (2024). Progesterone Test. https://my.clevelandclinic.org/health/diagnostics/22466-progesterone-test
  • Crawford, N., et al. (2024). Progesterone Monitoring in Natural and Assisted Conception Cycles. Fertility and Sterility, 121(2).
  • Nagy, B., et al. (2021). Key to Life: Physiological Role and Clinical Implications of Progesterone. International Journal of Molecular Sciences, 22(20), 11039. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536935/
  • Prior, J. C. (2023). Progesterone for treatment of symptomatic menopausal women. Climacteric, 26(2), 128-133. https://pubmed.ncbi.nlm.nih.gov/36847802/
  • Regidor P. A. (2014). Progesterone in Peri- and Postmenopause: A Review. Geburtshilfe und Frauenheilkunde, 74(11), 995-1002.
  • Santoro, N. (2024). Hormone Testing in Reproductive Medicine: Current Perspectives. Journal of Women's Health, 33(3).
  • Sundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020). Progesterone – Friend or foe? Frontiers in Neuroendocrinology, 59, 100856.

About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.